Navigation Links
Christiana Care Breast Center First in Delaware to Earn American College of Radiology Accreditation
Date:5/4/2011

WILMINGTON, Del., May 4, 2011 /PRNewswire-USNewswire/ -- The Christiana Care Breast Center at the Helen F. Graham Cancer Center has been awarded a three-year term of accreditation in breast Magnetic Resonance Imaging (MRI) by the American College of Radiology (ACR).

(Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO)

The Christiana Care Breast Center is the only facility in Delaware to earn this prestigious award. MRI of the breast offers valuable information about many breast conditions that other imaging modalities, such as mammography or ultrasound, might not obtain.

The ACR gold seal of accreditation represents the highest level of image quality and patient safety. Facilities achieve the award if they meet ACR practice guidelines and technical standards after a peer-review evaluation by board-certified physicians and expert medical physicists. The evaluation assesses image quality, personnel qualifications, adequacy of facility equipment, quality control procedures and quality assurance programs.

The Christiana Care Breast Center is the only facility in the region devoted exclusively to breast care, diagnosis and treatment. It offers the region's only dedicated breast MRI unit.

The ACR is a national professional organization serving more than 34,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians and medical physicists.

For more information about Christiana Care, visit www.christianacare.org.


'/>"/>
SOURCE Christiana Care Health System
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Christiana Care Health System Rolls Out Electronic Computerized Provider Order Entry
2. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
3. Christiana Care Health System Leads National Colorectal Cancer Clinical Trial
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
7. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
8. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
9. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
10. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
11. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... Abilene, Texas (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... says, reveals which name the Creator responds to and which He does not. Yisrayl ... to believe which one is the true name, but he says with a little Scripture, ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a ... he has leant his presence to an educational purpose as the host of the ... one being cancer. In a recent episode, the series focuses on thyroid cancer. , ...
Breaking Medicine News(10 mins):